The full report is titled “Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes. A Cost-Effectiveness Analysis.” The authors are N. Laiteerapong, J.M. Cooper, M.R. Skandari, P.M. Clarke, A.N. Winn, R.N. Naylor, and E.S. Huang.
Cost-Effectiveness of Individualized Management of Diabetes Among U.S. Adults. Ann Intern Med. 2018;168:I–22. [Epub ahead of print 12 December 2017]. doi: https://doi.org/10.7326/P17-9050
Download citation file:
Published: Ann Intern Med. 2018;168(3):I-22.
Published at www.annals.org on 12 December 2017
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Healthcare Delivery and Policy.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use